Taiwan’s leading animal & pet pharma company—Vetnostrum Animal Health (6936.TWO)—has officially gone public!
Led by third-generation pharma leader Wei-Kai Chung of Yung Shin Pharm., Vetnostrum has expanded rapidly since acquiring Zoetis Biotech for NT$800M in 2016. Today, the company holds 300+ drug licenses and a strong presence in both livestock and pet medicine.
Fast Facts:

• Profitable since year one
• Record-breaking revenue of NT$1.294B
• Focus on precision medicine & green aquaculture

With a bold 3-year plan, Vetnostrum is set to become the APAC region’s top animal pharma company!
Read more: https://reurl.cc/vp20lL
Follow #Globalbio for more biotech & pharma industry insights!
#AnimalHealth #PetPharma #GreenAquaculture #PrecisionMedicine #BiotechInnovation #Vetnostrum #Globalbio #SustainableFarming #VeterinaryMedicine